Related Experiment Video
Updated: Jun 25, 2026
06:31
Erosion Identification in Metacarpophalangeal Joints in Rheumatoid Arthritis using High-Resolution Peripheral Quantitative Computed Tomography
Published on: October 6, 2023
[Denosumab, the rheumatologist's joker?].
1Service de rhumatologie, médecine physique et rééducation et Centre des maladies osseuses Département de l'appareil locomoteur, CHUV, 1011 Lausanne. berengere.aubry@chuv.ch
Revue Medicale Suisse
|February 17, 2009
Summary
Denosumab, a new antibody targeting RANKL, effectively treats postmenopausal osteoporosis and prevents bone erosion in rheumatoid arthritis. This molecule offers a promising, well-tolerated therapeutic option for bone conditions.
Area of Science:
- Bone biology and molecular therapeutics.
- Immunology and rheumatology.
Context:
- Increasing number of therapeutic molecules targeting bone turnover.
- Established need for effective treatments for osteoporosis and rheumatoid arthritis-related bone erosions.
Purpose:
- To evaluate the efficacy and safety of denosumab, a monoclonal antibody against RANKL.
- To assess denosumab's role in managing postmenopausal osteoporosis and preventing bone erosions in rheumatoid arthritis.
Summary:
- Denosumab, a human monoclonal antibody targeting Receptor Activator of Nuclear factor-KB ligand (RANKL), demonstrates significant efficacy.
- It effectively decreases fracture risk in postmenopausal osteoporosis and prevents new bone erosions in rheumatoid arthritis.
- The agent is easy to administer, acts rapidly, and provides sustained benefits with excellent tolerance.
Impact:
- Denosumab represents a significant advancement in the treatment of bone diseases.
- It offers a new therapeutic strategy for postmenopausal osteoporosis and rheumatoid arthritis.
- Further clinical adoption is anticipated following its licensing.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:27Degenerative Disc Disease I: Introduction
Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...